CRP and angina pectoris: Of the 2925 subjects with CRP measured in the MIRACL study, 127 (4%) died, 205 (7%) had recurrent myocardial infarction, and 215 (7%) had recurrent unstable angina with objective evidence of ischemia over the 16 weeks of the study.